Updates in Anthracycline-Mediated Cardiotoxicity

by Canan G. Nebigil, Laurent Désaubry
Published 2018-11-01

Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments

by Anais Audebrand, Laurent Désaubry, Canan G. Nebigil
Published 2020-01-01

Correction: Nguyen T.L., et al. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells. <i>J. Dev. Biol.</i> 2013, <i>1</i>, 20–31

by Thu Lan Nguyen, Adeline Gasser, Canan G. Nebigil
Published 2020-12-01

Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells

by Canan G. Nebigil, Thu Lan Nguyen, Adelin Gasser
Published 2013-06-01

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside

by Canan G. Nebigil, Michael W. Y. Chan, Tienush Rassaf
Published 2020-08-01

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies

by Po-Yen Hsu, Aynura Mammadova, Nadia Benkirane-Jessel, Laurent Désaubry, Canan G. Nebigil
Published 2021-07-01

Discovery of A class GPCR ligands for probing signal transduction pathways

by Simone eBrogi, Canan G. Nebigil-Desaubry, Andrea eTafi, Laurent G. Désaubry
Published 2014-11-01

Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27.

by Yohann Bernard, Nigel Ribeiro, Frédéric Thuaud, Gülen Türkeri, Ronan Dirr, Mounia Boulberdaa, Canan G Nebigil, Laurent Désaubry
Published 2011-01-01

Cancer wars: Natural products strike back

by Christine eBasmadjian, Qian eZhao, Amel eDjehal, Embarek eBentouhami, Canan G Nebigil, Canan G Nebigil, Roger A Johnson, Maria eSerova, Armand eDe Gramont, Sandrine eFaivre, Eric eRaymond, Laurent G. Désaubry
Published 2014-05-01

FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity.

by Rehana Qureshi, Onur Yildirim, Adeline Gasser, Christine Basmadjian, Qian Zhao, Jean-Philippe Wilmet, Laurent Désaubry, Canan G Nebigil
Published 2015-01-01

Prokineticin receptor 1 as a novel suppressor of preadipocyte proliferation and differentiation to control obesity.

by Cécilia Szatkowski, Judith Vallet, Mojdeh Dormishian, Nadia Messaddeq, Phillippe Valet, Mounia Boulberdaa, Daniel Metzger, Pierre Chambon, Canan G Nebigil
Published 2013-01-01

Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1.

by Adeline Gasser, Simone Brogi, Kyoji Urayama, Toshishide Nishi, Hitoshi Kurose, Andrea Tafi, Nigel Ribeiro, Laurent Désaubry, Canan G Nebigil
Published 2015-01-01

Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection

by Adeline Gasser, PhD, Yu-Wen Chen, MD, PhD, Anais Audebrand, MSci, Ayhan Daglayan, MSci, Marine Charavin, PhD, Brigitte Escoubet, MD, PhD, Pavel Karpov, PhD, Igor Tetko, PhD, Michael W.Y. Chan, PhD, Daniela Cardinale, MD, PhD, Laurent Désaubry, PhD, Canan G. Nebigil, PharmD, PhD
Published 2019-09-01